Please login to the form below
45
Revenue 2017Zytiga
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.
CHMP turns down BMS’ Opdivo/Yervoy for kidney cancer
The decision comes after a clinical study suggested that patients given Xofigo in combination with Zytiga (abiraterone acetate) and prednisone/prednisolone could be at risk of dying earlier and had more
Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use
The expanded licence will help it compete with J&J’S rival treatment Zytiga, which has also been broadening into patients with earlier stage disease.
Daily Brief: NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal
Daily Brief:NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal. ... UK Market Access. NICE says no to Zytiga. NICE has rejected Janssen’s Zytiga plus androgen deprivation therapy (ADT) for men with untreated high-risk
EMA starts review of Xtandi in non-metastatic prostate cancer
At the moment Xtandi - like longstanding rival Zytiga (abiraterone acetate) from Johnson &Johnson - is only prescribed for men with advanced CRPC that has spread and no longer responds to hormone therapy.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Scientific Team Lead
-
Competitive Salary
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Director Healthcare PR Communications
-
Salary TBC
-
Associate Medical Director
-
Salary TBC
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Negotiable
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Experienced Editor, London, Medical Communications
-
Competitive package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Associate Medical Director
-
Highly Competitive
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Account Director – Global Healthcare PR
-
Salary TBC
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
Subscribe to our email news alerts
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- 90TEN wins big at PRWeek Awards taking home six accolades including Mid-Sized and Specialist Consultancy of the Year
- The NHS in 2022: how pharma can contribute to new models of care
- Genomics England chooses Congenica for diagnostic decision support
- Ocrevus surge keeps Roche smiling in Q3
- First Humira biosimilars reach EU market
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
- Tackling a formidable foe
- Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Quick links
Infographics
